| Pathologic grading for predicting metastasis in phaeochromocytoma and paraganglioma. NM Kimura N, Takayanagi R, Takizawa N, Itagaki E, Katabami T, Kakoi N ... Endocr Relat Cancer. 21 (3), 405-14, 2014 | 295 | 2014 |
| Prevalence of cardiovascular disease and its risk factors in primary aldosteronism: a multicenter study in Japan Y Ohno, M Sone, N Inagaki, T Yamasaki, O Ogawa, Y Takeda, I Kurihara, ... Hypertension 71 (3), 530-537, 2018 | 180 | 2018 |
| Relationship between clinical markers of glycemia and glucose excursion evaluated by continuous glucose monitoring (CGM). T Suwa, A Ohta, T Matsui, R Koganei, H Kato, T Kawata, Y Sada, S Ishii, ... Endocrine journal 57 (2), 135-140, 2010 | 133 | 2010 |
| Histopathological diagnosis of primary aldosteronism using CYP11B2 immunohistochemistry K Nanba, M Tsuiki, K Sawai, K Mukai, K Nishimoto, T Usui, T Tagami, ... The Journal of Clinical Endocrinology & Metabolism 98 (4), 1567-1574, 2013 | 119 | 2013 |
| Diagnosis and treatment of adrenal insufficiency including adrenal crisis: a Japan Endocrine Society clinical practice guideline [Opinion] T Yanase, T Tajima, T Katabami, Y Iwasaki, Y Tanahashi, A Sugawara, ... Endocrine journal 63 (9), 765-784, 2016 | 90 | 2016 |
| High prevalence of diabetes in patients with primary aldosteronism (PA) associated with subclinical hypercortisolism and prediabetes more prevalent in bilateral than unilateral … Y Akehi, T Yanase, R Motonaga, H Umakoshi, M Tsuiki, Y Takeda, ... Diabetes Care 42 (5), 938-945, 2019 | 87 | 2019 |
| Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021 M Naruse, T Katabami, H Shibata, M Sone, K Takahashi, A Tanabe, ... Endocrine journal 69 (4), 327-359, 2022 | 86 | 2022 |
| Significance of computed tomography and serum potassium in predicting subtype diagnosis of primary aldosteronism H Umakoshi, M Tsuiki, Y Takeda, I Kurihara, H Itoh, T Katabami, T Ichijo, ... The Journal of Clinical Endocrinology & Metabolism 103 (3), 900-908, 2018 | 84 | 2018 |
| New diagnostic criteria of adrenal subclinical Cushing’s syndrome: opinion from the Japan Endocrine Society T Yanase, Y Oki, T Katabami, M Otsuki, K Kageyama, T Tanaka, H Kawate, ... Endocrine journal 65 (4), 383-393, 2018 | 83 | 2018 |
| Accuracy of adrenal computed tomography in predicting the unilateral subtype in young patients with hypokalaemia and elevation of aldosterone in primary aldosteronism H Umakoshi, T Ogasawara, Y Takeda, I Kurihara, H Itoh, T Katabami, ... Clinical Endocrinology 88 (5), 645-651, 2018 | 71 | 2018 |
| Obesity as a key factor underlying idiopathic hyperaldosteronism Y Ohno, M Sone, N Inagaki, T Yamasaki, O Ogawa, Y Takeda, I Kurihara, ... The Journal of Clinical Endocrinology & Metabolism 103 (12), 4456-4464, 2018 | 59 | 2018 |
| Development and validation of subtype prediction scores for the workup of primary aldosteronism H Kobayashi, M Abe, M Soma, Y Takeda, I Kurihara, H Itoh, H Umakoshi, ... Journal of hypertension 36 (11), 2269-2276, 2018 | 58 | 2018 |
| Prognosis of primary aldosteronism in Japan: results from a nationwide epidemiological study Y Miyake, K Tanaka, T Nishikawa, M Naruse, R Takayanagi, H Sasano, ... Endocrine journal 61 (1), 35-40, 2014 | 55 | 2014 |
| Clinical and biochemical outcomes after adrenalectomy and medical treatment in patients with unilateral primary aldosteronism T Katabami, H Fukuda, H Tsukiyama, Y Tanaka, Y Takeda, I Kurihara, ... Journal of hypertension 37 (7), 1513-1520, 2019 | 52 | 2019 |
| Importance of contralateral aldosterone suppression during adrenal vein sampling in the subtype evaluation of primary aldosteronism H Umakoshi, K Tanase‐Nakao, N Wada, T Ichijo, M Sone, N Inagaki, ... Clinical endocrinology 83 (4), 462-467, 2015 | 52 | 2015 |
| Phaeochromocytoma Study Group in Japan. Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma N Kimura, R Takayanagi, N Takizawa, E Itagaki, T Katabami, N Kakoi, ... Endocr Relat Cancer 21 (3), 405-414, 2014 | 50 | 2014 |
| Association between acute fall in estimated glomerular filtration rate after treatment for primary aldosteronism and long-term decline in renal function H Kobayashi, M Abe, Y Nakamura, K Takahashi, M Fujita, Y Takeda, ... Hypertension 74 (3), 630-638, 2019 | 48 | 2019 |
| Controlling tumor progression with cyclophosphamide, vincristine, and dacarbazine treatment improves survival in patients with metastatic and unresectable malignant … S Asai, T Katabami, M Tsuiki, Y Tanaka, M Naruse Hormones and Cancer 8, 108-118, 2017 | 48 | 2017 |
| Serum free testosterone and metabolic syndrome in Japanese men T Katabami, H Kato, T Asahina, S Hinohara, T Shin, T Kawata, A Ohta, ... Endocrine journal 57 (6), 533-539, 2010 | 42 | 2010 |
| Discrepancies in results of low-and high-dose dexamethasone suppression tests for diagnosing preclinical Cushing's syndrome T Katabami, R Obi, N Shirai, S Naito, N Saito Endocrine journal 52 (4), 463-469, 2005 | 40 | 2005 |
